Effect of a DPP-4 inhibitor on left ventricular diastolic dysfunction in patients with type 2 diabetes and diabetic cardiomyopathy.
Phase of Trial: Phase III
Latest Information Update: 13 May 2016
At a glance
- Drugs Sitagliptin (Primary) ; Voglibose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Jun 2013 Planned end date changed from 1 Mar 2012 to 30 Jun 2013 as reported by University Hospital Medical Information Network - Japan record.
- 27 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 20 Dec 2011 New trial record